scispace - formally typeset
R

Renata Cifkova

Researcher at First Faculty of Medicine, Charles University in Prague

Publications -  319
Citations -  91912

Renata Cifkova is an academic researcher from First Faculty of Medicine, Charles University in Prague. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 68, co-authored 305 publications receiving 80868 citations. Previous affiliations of Renata Cifkova include Masaryk University & Czechoslovak Academy of Sciences.

Papers
More filters
Journal ArticleDOI

Cyclosporin-induced hypertension.

Renata Cifkova, +1 more
- 01 Dec 2001 - 
TL;DR: Improved survival rates with cyclosporin compared to previous regimens based on corticosteroids and azathioprine were established and have led to an expansion of solid organ transplantation.
Journal ArticleDOI

N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest heart failure

Otto Mayer, +4 more
- 09 Apr 2009 - 
TL;DR: The asymptomatic elevation of NT-proBNP provides prognostic information also in stable coronary patients not yet manifesting any symptoms of heart failure, as well as in patients with stable chronic coronary heart disease.
Journal ArticleDOI

Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension

Renata Cifkova, +7 more
- 01 Jun 2000 - 
TL;DR: No significant differences were found in ldl-cholesterol and in other lipid parameters with the exception of hdl- cholesterol which was significantly higher on vt and the incidence of adverse events was higher on ch while both fixed combinations significantly lowered bp.
Journal ArticleDOI

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey

Delphine De Smedt, +22 more
- 01 Dec 2018 - 
TL;DR: Optimized guidelines adherence is more cost-effective in higher risk patients, in patients with higher risk reductions and when using a less strict LDL-C target.
Journal ArticleDOI

European guidelines on cardiovascular disease prevention in clinical practice - Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) (vol 171, pg 145, 2003)

Gui De Backer, +20 more
- 01 Apr 2004 -